Targeted Medical Pharma, Inc. 4
4 · Targeted Medical Pharma, Inc. · Filed Nov 25, 2013
Insider Transaction Report
Form 4
Nemiroff Arthur R.
Director
Transactions
- Sale
Common Stock, $.001 par value per share
2013-11-19$0.91/sh−9,000$8,190→ 45,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $0.95 per share.